World's Best Scientists 2026 revealed!
Robert B. Zipursky

Robert B. Zipursky

D-Index & Metrics

Medicine

D-Index
83
Citations
25802
World Ranking
15584
National Ranking
649

Overview

Robert B. Zipursky is affiliated with the University of Toronto in Canada and is engaged in research primarily within the fields of Medicine and Psychology. Their work extensively covers Psychiatry and Mental Health, Clinical Psychology, as well as Social Psychology, Experimental and Cognitive Psychology, and Philosophy.

The researcher focuses on topics including Schizophrenia research and treatment, Mental Health Treatment and Access, Bipolar Disorder and Treatment, Child and Adolescent Psychosocial and Emotional Development, Mental Health and Psychiatry, and broader Mental Health Research Topics. Additional areas of interest include Anxiety, Depression, Psychometrics, Treatment, and Cognitive Processes.

Frequent coauthors collaborating with Zipursky are:

  • Ofer Agid
  • Gary Remington
  • Michael Kiang
  • Sri Mahavir Agarwal
  • Joel Dissanayake

Publications involving Zipursky appear mainly in these venues:

  • The Canadian Journal of Psychiatry
  • PLoS ONE
  • Schizophrenia Research
  • Emerging Adulthood
  • Pediatric Research

Representative recent papers authored or coauthored by Robert B. Zipursky include:

  • You say "schizophrenia" and I say "psychosis": Just tell me when I can come off this medication, 2020, Schizophrenia Research
  • Mary V. Seeman: In Memoriam, 2024, The Canadian Journal of Psychiatry
  • Rethinking Schizophrenia-A Manageable Chronic Condition, 2024, The Canadian Journal of Psychiatry

Other publications connected to their field include:

  • Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol, 2023, PLoS ONE
  • Modeling the Reduction of Attrition in Campus Mental Health Services: A Discrete Choice Conjoint Experiment, 2020, Emerging Adulthood

Best Publications

  • A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood.

    Adolf Pfefferbaum;Daniel H. Mathalon;Edith V. Sullivan;Jody M. Rawles

  • Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia

    Shitij Kapur;Robert Zipursky;Corey Jones;Gary Remington

  • Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.

    Shitij Kapur;Robert B. Zipursky;Gary Remington

  • Antipsychotic drug effects on brain morphology in first-episode psychosis

    Jeffrey A. Lieberman;Jeffrey A. Lieberman;Gary D. Tollefson;Cecil Charles;Robert Zipursky

  • Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis.

    Thomas H. McGlashan;Robert B. Zipursky;Diana Perkins;Jean Addington

  • Brain Gray and White Matter Volume Loss Accelerates with Aging in Chronic Alcoholics: A Quantitative MRI Study

    Adolf Pfefferbaum;Kelvin O. Lim;Kelvin O. Lim;Robert B. Zipursky;Robert B. Zipursky;Daniel H. Mathalon;Daniel H. Mathalon

  • Delayed-Onset Hypothesis of Antipsychotic Action: A Hypothesis Tested and Rejected

    Ofer Agid;Shitij Kapur;Tamara Arenovich;Robert B. Zipursky

  • Widespread cerebral gray matter volume deficits in schizophrenia.

    Robert B. Zipursky;Kelvin O. Lim;Kelvin O. Lim;Edith V. Sullivan;Edith V. Sullivan;Byron W. Brown

  • A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.

    Shitij Kapur;Robert Zipursky;Corey Jones;C. S. Shammi

  • Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Haloperidol

    Jeffrey A. Lieberman;Gary Tollefson;Mauricio Tohen;Alan I. Green

  • 5-HT2 and D2 Receptor Occupancy of Olanzapine in Schizophrenia: A PET Investigation

    Shitij Kapur;Robert B. Zipursky;Gary Remington;Corey Jones

  • A systematic review of longitudinal outcome studies of first-episode psychosis

    N. M. Menezes;T. Arenovich;R. B. Zipursky

  • The Myth of Schizophrenia as a Progressive Brain Disease

    Robert B. Zipursky;Thomas J. Reilly;Robin M. Murray

  • Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.

    Kate McKenna;Gideon Koren;Maria Tetelbaum;Lynda Wilton

  • Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study.

    Simone Silvestri;Mary V. Seeman;Juan-Carlos Negrete;Sylvain Houle

  • Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation.

    Zafiris Jeff Daskalakis;Bruce K Christensen;Robert Chen;Paul B Fitzgerald

  • A longitudinal study of neurocognitive function in individuals at-risk for psychosis.

    Richard S.E. Keefe;Diana O. Perkins;Hongbin Gu;Robert B. Zipursky

  • The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A pet study

    Shitij Kapur;Gary Remington;Robert B Zipursky;Alan A Wilson

  • A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis.

    Jean Addington;Irvin Epstein;Lu Liu;Paul French;Paul French

  • High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study

    Shitij Kapur;Gary Remington;Corey Jones;Alan Wilson

Frequent Co-Authors

Shitij Kapur
Shitij Kapur King's College London
Gary Remington
Gary Remington Centre for Addiction and Mental Health
Bruce K. Christensen
Bruce K. Christensen Australian National University
Adolf Pfefferbaum
Adolf Pfefferbaum Stanford University
Mauricio Tohen
Mauricio Tohen University of New Mexico
Diana O. Perkins
Diana O. Perkins University of North Carolina at Chapel Hill
Sylvain Houle
Sylvain Houle University of Toronto
Edith V. Sullivan
Edith V. Sullivan Stanford University
Kelvin O. Lim
Kelvin O. Lim University of Minnesota
René S. Kahn
René S. Kahn Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online education can provide new opportunities for those interested in healthcare and medicine. If you’re considering alternatives or pathways to support a medical career, there are several accredited online programs to help you get started.

For those pursuing healthcare administration, it’s essential to choose which online healthcare degree programs are recognized for their accreditation by cahme? Accreditation ensures the program meets high standards and is valued by employers.

Nursing professionals can advance their credentials through flexible study options. Some schools now offer rn to bsn no clinical hours, making it easier for working nurses to earn a bachelor’s degree without additional in-person requirements.

If you’re looking to move into advanced practice or leadership, consider the fastest dnp online program for a quicker path to the Doctor of Nursing Practice. Prefer a more manageable load? You can explore the shortest dnp program, designed for efficiency while maintaining educational quality.

Online healthcare degrees continue to expand, offering flexible, accredited options whether you are starting out or looking to advance in your career.

Best Scientists Citing Robert B. Zipursky

Trending Scientists